Abstracts (HTML) List of Authors

Sandborn, W

Efficacy of Ustekinumab for Ulcerative Colitis Through 2 Years: Results of the UNIFI Maintenance Study and Long-term Extension
Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension

Sands, B

Efficacy of Ustekinumab for Ulcerative Colitis Through 2 Years: Results of the UNIFI Maintenance Study and Long-term Extension
Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension

Santler, G

Elevation of liver enzyme under immunotherapy with checkpoint inhibitors

Scalori, A

ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL INDUCTION (OLI) COHORT

Scarpatetti, M

Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use

Schaefer, B

The PNPLA3 G-allele is common in patients with HCC but does not affect tumor characteristics and tumor biology

Schäfer, B

DAA therapy for chronic hepatitis c infection: risk factors for nonadherence and relapse
Neurodegenerative patterns in Wilson disease with hepatic or neurological manifestation assessed by morphometric magnetic resonance imaging
Penetrance, cancer incidence and survival of hemochromatosis in a long-term follow-up and epidemiological modeling study

Scharnagl, H

Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling

Schaufler, D

Humoral biomarkers of hemodynamic derangement in distinct stages of portal hypertension
Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study

Scheiner, B

The impact of novel systemic treatment options on the outcome of patients with hepatocellular carcinoma
Predictors of response to immunotherapy in patients with hepatocellular carcinoma - a retrospective single-center experience
Regorafenib dosing in patients with advanced hepatocellular carcinoma (HCC) - a retrospective real-world experience
Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Assessment of coagulopathy by rotational thromboelastometry in patients with cirrhosis and portal hypertension
Use of human albumin in a large “real-life” single-center cohort of patients with decompensated advanced chronic liver disease
Incidence and outcome of acute-on-chronic liver failure in a large retrospective single-center cohort
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy

Scherfler, C

Neurodegenerative patterns in Wilson disease with hepatic or neurological manifestation assessed by morphometric magnetic resonance imaging

Scherl, A

ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL INDUCTION (OLI) COHORT

Scherl, E

Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension

Schippinger, W

Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use

Schlager, H

Die Endosonographie-gezielte Gastroenterostomie bei maligner Magenausgangsstenose - erste Erfahrungswerte
Ein seltener und lange Zeit unklarer Fall: IgG4 - assoziierte Ösophagitis

Schleischitz, A

Endosonographisch gezielte Radiofrequenzablation zur Behandlung benigner Insulinome

Schmidbauer, C

Real-Life Perceptions on the Use of Albumin in Patients with Liver Cirrhosis in Specialized Gastroenterology Units in Austria
Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
“Let’s end hepatitis C in Vienna” - the first HCV elimination program targeting homeless and people without medical insurance in Vienna
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria
Real-Life Perceptions on the management and prevention of variceal bleeding in Specialized Gastroenterology Units in Austria

Schmidt, R

Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use

Schöfl, R

Respiratorische Infekte in den nächsten 14 Tagen unter Teilnehmern eines zweitägigen medizinischen Treffens
Diagnosespezifische Gesundheitsinformationen für Laien
Diagnosespezifische Handlungsempfehlungen für Hausärzte
Konsekutive rechtsanhängige fachspezifische Komplikationen über 5 Jahrean einer Abteilung für Gastroenterologie und Hepatologie

Scholl-Bürg, Si

Personalisierte Ernährungsmedizin am Beispiel einer Patientin mit Propionazidämie

Schönherr, E

The PNPLA3 G-allele is common in patients with HCC but does not affect tumor characteristics and tumor biology

Schreiner, C

Diagnosespezifische Gesundheitsinformationen für Laien
Diagnosespezifische Handlungsempfehlungen für Hausärzte

Schubert, R

Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria

Schütz, A

Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria

Schwabl, P

Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Assessment of coagulopathy by rotational thromboelastometry in patients with cirrhosis and portal hypertension
Use of human albumin in a large “real-life” single-center cohort of patients with decompensated advanced chronic liver disease
Incidence and outcome of acute-on-chronic liver failure in a large retrospective single-center cohort
Features of the portal hypertensive syndrome in patients with advanced PBC
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Humoral biomarkers of hemodynamic derangement in distinct stages of portal hypertension
Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy

Schwaighofer, H

Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.

Schwanke, C

Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria

Schwarz, M

Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
“Let’s end hepatitis C in Vienna” - the first HCV elimination program targeting homeless and people without medical insurance in Vienna
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria

Schwärzler, J

Gastric banding-associated weight loss diminishes hepatic Tsukushi expression

Schweizer, U

Interventionsfähiges Trainingsmodell für die flexible Endoskopie bei postoperativ veränderter Anatomie des oberen GI-Traktes

Schwenoha, K

Screening for chronic liver diseases in the general population reveals an unexpectedly high prevalence of hepatitis c and advanced NAFLD

Sebastian, B

Should colonoscopy screening recommendations be sex-specific and age adjusted?

Seemann, C

Endoskopische Raritäten - eine kleine Sammlung.

Seidl, M

Endoskopischer Verschluss einer Anastomosendehiszenz nach Hemikolektomie mit dem OverStitch™ Endoscopic Suturing System

Semlitsch, S

Respiratorische Infekte in den nächsten 14 Tagen unter Teilnehmern eines zweitägigen medizinischen Treffens

Semmler, G

Screening for chronic liver diseases in the general population reveals an unexpectedly high prevalence of hepatitis c and advanced NAFLD
Effect of nut consumption on prevalence and severity of NAFLD, cardiovascular diseases and metabolic disorders
NAFLD in lean patients is associated with an increased cardiovascular risk, prediabetes and the metabolic syndrome
Use of human albumin in a large “real-life” single-center cohort of patients with decompensated advanced chronic liver disease
Incidence and outcome of acute-on-chronic liver failure in a large retrospective single-center cohort
Alcohol consumption and the risk for colorectal adenoma
Should colonoscopy screening recommendations be sex-specific and age adjusted?
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy

Sheri, V

Pregnancy Outcomes in Women with Psoriasis, Psoriatic Arthritis, Crohn’s Disease, and Ulcerative Colitis Treated with Ustekinumab

Shiffman, ML

Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis

Shinozaki, K

Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)

Siebenbrunner, B

Humoral biomarkers of hemodynamic derangement in distinct stages of portal hypertension

Siegmund, K

Nampt Inhibition, ein neuer Therapieansatz bei akuter graft-versus-host-disease.

Simbrunner, B

Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Assessment of coagulopathy by rotational thromboelastometry in patients with cirrhosis and portal hypertension
Use of human albumin in a large “real-life” single-center cohort of patients with decompensated advanced chronic liver disease
Incidence and outcome of acute-on-chronic liver failure in a large retrospective single-center cohort
Features of the portal hypertensive syndrome in patients with advanced PBC
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy

Sloan, S

Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudy

Solfrank, B

Antitumor activity of larotrectinib in esophageal carcinoma with NTRK gene amplification

Spindelböck, W

Die Endosonographie-gezielte Gastroenterostomie bei maligner Magenausgangsstenose - erste Erfahrungswerte

Stadlbauer, V

Sarcopenia and liver cirrhosis- Comparison of the European Working group on Sarcopenia criteria 2010 and 2019
A novel score to predict mortality after transjugular intrahepatic portosystemic shunt in patients with renal insufficiency
Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use
Increased resting respiratory burst and decreased phagocytosis and chemotaxis: how bile acids impair neutrophil response in liver cirrhosis

Stadlbauer-Köllner, V

Real-Life Perceptions on the Use of Albumin in Patients with Liver Cirrhosis in Specialized Gastroenterology Units in Austria
Where have all the women gone? - Die Repräsentation von Frauen in der Gastroenterologie und Hepatologie in Österreich
Die Auswirkungen eines multispezies-Synbiotikums auf Mikrobiom-assoziierte Nebenwirkungen einer Langzeit-Protonen-Pumpen-Hemmer Therapie: Eine Pilotstudie
Real-Life Perceptions on the management and prevention of variceal bleeding in Specialized Gastroenterology Units in Austria
Fibroscan® probe selection for lean adults

Stadlmann, A

Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Assessment of coagulopathy by rotational thromboelastometry in patients with cirrhosis and portal hypertension
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease

Stahlmann, M

Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling

Stangassinger, L

Screening for chronic liver diseases in the general population reveals an unexpectedly high prevalence of hepatitis c and advanced NAFLD

Stättermayer, A

The gastrointestinal bleeding registry at the University Hospital St. Pölten, Austria-A prospective evaluation
Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease

Stättermayer, AF

Features of the portal hypertensive syndrome in patients with advanced PBC
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy

Stättermayer, M

The gastrointestinal bleeding registry at the University Hospital St. Pölten, Austria-A prospective evaluation

Stauber, R

Fibroscan® probe selection for lean adults

Steindl-Munda, P

Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Non-invasive risk stratification by VCTE and VITRO after HCV eradication

Steiner, E

Chronic pancreatitis in the northeast of Austria. First epidemiological data from the Pancreas Outpatient Clinic St. Pölten
Acute pancreatitis in the northeast of Austria. First epidemiological data from the Pancreas Outpatient Clinic St. Pölten.

Steiner, P

The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease

Steinwender, M

Die Auswirkungen eines multispezies-Synbiotikums auf Mikrobiom-assoziierte Nebenwirkungen einer Langzeit-Protonen-Pumpen-Hemmer Therapie: Eine Pilotstudie

Stift, J

Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy

Stimakovits, J

Endosonographisch gezielte Radiofrequenzablation zur Behandlung benigner Insulinome

Stojakovic, T

Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling

Stradner, M

Ein seltener und lange Zeit unklarer Fall: IgG4 - assoziierte Ösophagitis

Strasser, M

The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects

Strebinger, G

The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects

Streit, A

Fibroscan® probe selection for lean adults

Svoboda, C

Endosonographisch gezielte Radiofrequenzablation zur Behandlung benigner Insulinome